DR-18

Serial Number 99464030
630

Registration Progress

Application Filed
Oct 27, 2025
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

DR-18

Basic Information

Serial Number
99464030
Filing Date
October 27, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
630
Status Date
Oct 27, 2025
Application
Pending
Classes
001 005

Rights Holder

Simcha IL-18, Inc.

03
Address
157 Church Street, 19th Floor
New Haven, CT 06510

Ownership History

Simcha IL-18, Inc.

Original Applicant
03
New Haven, CT

Legal Representation

Attorney
William S. Fultz

Application History

2 events
Date Code Type Description Documents
Oct 27, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Oct 27, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
Biological and chemical preparations for use in scientific and medical research; Biological and chemical preparations for use in the manufacture of pharmaceuticals; Biological and chemical preparations for use in the development of immunotherapies, cell therapies, and oncology treatments; Protein in raw material form for scientific and medical research; Engineered proteins for medical and scientific research; Engineered nucleic acids for medical and scientific research; Genetically-engineered cells for medical and scientific research; Therapeutic proteins, nucleic acids, and cells for use in the manufacture of pharmaceutical preparations
Class 005
Pharmaceutical products for the treatment of cancer; Anti-cancer preparations; Tumor suppressing agents; Pharmaceutical products for treatment of cancer by means of activation of the immune system; Pharmaceutical products for treatment of cancer by means of cell therapy; Biological preparations for use in oncology; Engineered cytokine proteins sold as a component ingredient of therapeutic pharmaceuticals for the treatment of cancer; Nucleic acids encoding engineered cytokine proteins sold as a component ingredient of therapeutic pharmaceuticals for the treatment of cancer; Cells genetically engineered to produce engineered cytokine proteins sold as a component ingredient of therapeutic pharmaceuticals for the treatment of cancer

Classification

International Classes
001 005